Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × HCC × Stents × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pancreatic Neoplasms 5 Cholangiocarcinoma 4 Colonic Neoplasms 3 Neoplasm Metastasis 2 Jaundice 2 Gallbladder Neoplasms 2 Bites and Stings 2 Bile Duct Neoplasms 2 Urologic Diseases 1 Urolithiasis 1 Urinary Calculi 1 Ureterolithiasis 1 Ureteral Obstruction 1 Stent Occlusion 1 Renal Insufficiency 1 Rectal Neoplasms 1 Pyonephrosis 1 Pyelonephritis 1 Nephrolithiasis 1 Kidney Diseases 1 Kidney Calculi 1 Infections 1 Hydronephrosis 1 Head and Neck Neoplasms 1 HCC 1 Fistula 1 Esophageal Neoplasms 1 Duodenal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

nimotuzumab 1 atezolizumab 1 Stents 1 Sorafenib 1 Radiotherapy 1 Radiosurgery 1 Radiofrequency Ablation 1 Immune Checkpoint Inhibitors 1 Hematologic Tests 1 Ethiodized Oil 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03108248 2017-04-11

ISP-TACE Versus TACE for HCC With PVTT

Zhongda Hospital

HCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡